CLOs on the Move

The Permanente Medical Group Inc

www.permanente.net

 
The Permanente Medical Group was established in 1948 with seven original partners. Today, we are an integral part of Kaiser Permanente with the stability of more than 50 years serving the communities of Northern California. As the quality leader in
  • Number of Employees: 25-100
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

ARTANN Laboratories (Main)

ARTANN Laboratories (Main) is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DOTMED.COM

DOTMED.COM Inc. is a New York, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

HistoRX

HistoRX is a Branford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Provista

Provista is a Irving, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Smith and Nephew

Smith & Nephew is a global advanced medical technology business. We support healthcare professionals in more than 100 countries to improve the quality of life for their patients. Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions. Through our market leadership positions in Sports Medicine, Trauma, Orthopaedic Reconstruction and Advanced Wound Management, our 16,000 employees continue to improve outcomes and expand access, constantly striving to create value for healthcare professionals, patients, payers and shareholders. Annual sales in 2016 were more than $4.6 billion. We are a constituent of the UK’s FTSE100 and our shares are traded on London Stock Exchange and through American Depository Receipts on the New York Stock Exchange   We have leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma.   We have almost 11,000 employees and a presence in more than 90 countries.   Annual sales in 2013 were more than $4.3 billion.   We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN)